ID

31204

Beschrijving

Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT01687439

Link

https://clinicaltrials.gov/show/NCT01687439

Trefwoorden

Versies (1)
  1. 28-07-18 28-07-18 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

28 juli 2018

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Non-small Cell Lung Cancer NCT01687439

Engels

Eligibility Non-small Cell Lung Cancer NCT01687439

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically proven inoperable stage iiib-iv nsclc
Beschrijving

Non-Small Cell Lung Carcinoma Inoperable TNM clinical staging

Datatype

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205187
UMLS CUI [1,3]
C3258246
ecog ps 0-1
Beschrijving

ECOG performance status

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy > 3 months
Beschrijving

Life Expectancy

Datatype

boolean

Alias
UMLS CUI [1]
C0023671
adequate blood functions: absolute neutrophil count (anc) ≥ 1.5 x 109/l, platelet count ≥ 100 x 109/l, and hemoglobin ≥ 9 g / dl
Beschrijving

Hematologic function | Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement

Datatype

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0948762
UMLS CUI [3]
C0032181
UMLS CUI [4]
C0518015
adequate liver function: total bilirubin <1.5 times the upper limit of normal (uln); ast and alt <2.5 times uln in patients without liver metastases, <5 times uln in patients with liver metastases
Beschrijving

Liver function | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Secondary malignant neoplasm of liver Absent | Secondary malignant neoplasm of liver Present

Datatype

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0201899
UMLS CUI [4]
C0201836
UMLS CUI [5,1]
C0494165
UMLS CUI [5,2]
C0332197
UMLS CUI [6,1]
C0494165
UMLS CUI [6,2]
C0150312
adequate renal function: serum creatinine ≤ 1.25 times uln or calculated creatinine clearance ≥ 50 ml / min and urinary protein <2+. in patients with baseline urinary protein ≥ 2+, 24 hours urine should be collected and 24 hours urine protein ≤ 1g
Beschrijving

Renal function | Creatinine measurement, serum | Estimation of creatinine clearance by Cockcroft-Gault formula | Proteinuria | 24 hour urine sample | 24 Hour urine volume measurement

Datatype

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0201976
UMLS CUI [3]
C2711451
UMLS CUI [4]
C0033687
UMLS CUI [5]
C0456209
UMLS CUI [6]
C0427843
international normalized ratio (inr) ≤ 1.5 and prothrombin time(pt) ≤ 1.5 times uln within 7 days before enrollment
Beschrijving

International Normalized Ratio | Prothrombin time assay

Datatype

boolean

Alias
UMLS CUI [1]
C0525032
UMLS CUI [2]
C0033707
written informed consent
Beschrijving

Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
evidence of bleeding diathesis or coagulopathy
Beschrijving

Bleeding tendency | Blood Coagulation Disorders

Datatype

boolean

Alias
UMLS CUI [1]
C1458140
UMLS CUI [2]
C0005779
history of hemoptysis, defined as bright red blood more than half a teaspoon 3 months before enrollment
Beschrijving

Hemoptysis

Datatype

boolean

Alias
UMLS CUI [1]
C0019079
previously received chemotherapy and radiotherapy and biological targeted therapy
Beschrijving

Prior Chemotherapy | Prior radiation therapy | Targeted Therapy biological

Datatype

boolean

Alias
UMLS CUI [1]
C1514457
UMLS CUI [2]
C0279134
UMLS CUI [3,1]
C2985566
UMLS CUI [3,2]
C0205460
uncontrolled hypertension (systolic blood pressure> 150 mmhg and/or diastolic blood pressure> 100 mm hg)
Beschrijving

Uncontrolled hypertension | Systolic Pressure | Diastolic blood pressure

Datatype

boolean

Alias
UMLS CUI [1]
C1868885
UMLS CUI [2]
C0871470
UMLS CUI [3]
C0428883
clinically significant (ie, active) cardiovascular diseases, such as cerebrovascular accident (within 6 months before initiating treatment), myocardial infarction (within 6 months before initiating treatment), unstable angina, congestive heart failure (new york heart association class ≥grade ii) , serious arrhythmia which needs medication during the study and may affect the study or can not be controlled by drugs
Beschrijving

Cardiovascular Diseases | Cerebrovascular accident | Myocardial Infarction | Angina, Unstable | Congestive heart failure New York Heart Association Classification | Cardiac Arrhythmia Serious Requirement Pharmaceutical Preparations | Cardiac Arrhythmia Affecting Clinical Trial | Cardiac Arrhythmia Pharmacotherapy Unsuccessful

Datatype

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0038454
UMLS CUI [3]
C0027051
UMLS CUI [4]
C0002965
UMLS CUI [5,1]
C0018802
UMLS CUI [5,2]
C1275491
UMLS CUI [6,1]
C0003811
UMLS CUI [6,2]
C0205404
UMLS CUI [6,3]
C1514873
UMLS CUI [6,4]
C0013227
UMLS CUI [7,1]
C0003811
UMLS CUI [7,2]
C0392760
UMLS CUI [7,3]
C0008976
UMLS CUI [8,1]
C0003811
UMLS CUI [8,2]
C0013216
UMLS CUI [8,3]
C1272705
unhealed wounds, active peptic ulcer or fracture
Beschrijving

Wound, non-healed | Peptic Ulcer | Fracture

Datatype

boolean

Alias
UMLS CUI [1]
C0750433
UMLS CUI [2]
C0030920
UMLS CUI [3]
C0016658
gastrointestinal fistula, gastrointestinal perforation or intra-abdominal abscess within 6 months before enrollment
Beschrijving

Digestive System Fistula | Gastrointestinal perforation | Abdominal Abscess

Datatype

boolean

Alias
UMLS CUI [1]
C0079238
UMLS CUI [2]
C0151664
UMLS CUI [3]
C0243001
women with intact uterus (menopause more than two years excluded) who are unwilling to take effective non-hormonal contraception (iud, spermicide barrier birth control device or sterilization) during the study. male who are unwilling to take effective contraceptive measures during the study
Beschrijving

Gender Uterus Intact | Menopause Excluded | Contraceptive methods Unwilling | Intrauterine Devices | Vaginal Spermicides | Contraception, Barrier | Female Sterilization | Gender Contraceptive methods Unwilling

Datatype

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0042149
UMLS CUI [1,3]
C0205266
UMLS CUI [2,1]
C0025320
UMLS CUI [2,2]
C0332196
UMLS CUI [3,1]
C0700589
UMLS CUI [3,2]
C0558080
UMLS CUI [4]
C0021900
UMLS CUI [5]
C0087145
UMLS CUI [6]
C0004764
UMLS CUI [7]
C0015787
UMLS CUI [8,1]
C0079399
UMLS CUI [8,2]
C0700589
UMLS CUI [8,3]
C0558080
participated in other clinical trials within 28 days before the initiation of treatment.
Beschrijving

Study Subject Participation Status

Datatype

boolean

Alias
UMLS CUI [1]
C2348568
allergic to any of the study drugs
Beschrijving

Hypersensitivity Investigational New Drugs

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
Terug naar het begin van de pagina

Similar models

Eligibility Non-small Cell Lung Cancer NCT01687439

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma Inoperable TNM clinical staging
Item
histologically or cytologically proven inoperable stage iiib-iv nsclc
boolean
C0007131 (UMLS CUI [1,1])
C0205187 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
ECOG performance status
Item
ecog ps 0-1
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy > 3 months
boolean
C0023671 (UMLS CUI [1])
Hematologic function | Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement
Item
adequate blood functions: absolute neutrophil count (anc) ≥ 1.5 x 109/l, platelet count ≥ 100 x 109/l, and hemoglobin ≥ 9 g / dl
boolean
C0221130 (UMLS CUI [1])
C0948762 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0518015 (UMLS CUI [4])
Liver function | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Secondary malignant neoplasm of liver Absent | Secondary malignant neoplasm of liver Present
Item
adequate liver function: total bilirubin <1.5 times the upper limit of normal (uln); ast and alt <2.5 times uln in patients without liver metastases, <5 times uln in patients with liver metastases
boolean
C0232741 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
C0494165 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
C0494165 (UMLS CUI [6,1])
C0150312 (UMLS CUI [6,2])
Renal function | Creatinine measurement, serum | Estimation of creatinine clearance by Cockcroft-Gault formula | Proteinuria | 24 hour urine sample | 24 Hour urine volume measurement
Item
adequate renal function: serum creatinine ≤ 1.25 times uln or calculated creatinine clearance ≥ 50 ml / min and urinary protein <2+. in patients with baseline urinary protein ≥ 2+, 24 hours urine should be collected and 24 hours urine protein ≤ 1g
boolean
C0232804 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C2711451 (UMLS CUI [3])
C0033687 (UMLS CUI [4])
C0456209 (UMLS CUI [5])
C0427843 (UMLS CUI [6])
International Normalized Ratio | Prothrombin time assay
Item
international normalized ratio (inr) ≤ 1.5 and prothrombin time(pt) ≤ 1.5 times uln within 7 days before enrollment
boolean
C0525032 (UMLS CUI [1])
C0033707 (UMLS CUI [2])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Bleeding tendency | Blood Coagulation Disorders
Item
evidence of bleeding diathesis or coagulopathy
boolean
C1458140 (UMLS CUI [1])
C0005779 (UMLS CUI [2])
Hemoptysis
Item
history of hemoptysis, defined as bright red blood more than half a teaspoon 3 months before enrollment
boolean
C0019079 (UMLS CUI [1])
Prior Chemotherapy | Prior radiation therapy | Targeted Therapy biological
Item
previously received chemotherapy and radiotherapy and biological targeted therapy
boolean
C1514457 (UMLS CUI [1])
C0279134 (UMLS CUI [2])
C2985566 (UMLS CUI [3,1])
C0205460 (UMLS CUI [3,2])
Uncontrolled hypertension | Systolic Pressure | Diastolic blood pressure
Item
uncontrolled hypertension (systolic blood pressure> 150 mmhg and/or diastolic blood pressure> 100 mm hg)
boolean
C1868885 (UMLS CUI [1])
C0871470 (UMLS CUI [2])
C0428883 (UMLS CUI [3])
Cardiovascular Diseases | Cerebrovascular accident | Myocardial Infarction | Angina, Unstable | Congestive heart failure New York Heart Association Classification | Cardiac Arrhythmia Serious Requirement Pharmaceutical Preparations | Cardiac Arrhythmia Affecting Clinical Trial | Cardiac Arrhythmia Pharmacotherapy Unsuccessful
Item
clinically significant (ie, active) cardiovascular diseases, such as cerebrovascular accident (within 6 months before initiating treatment), myocardial infarction (within 6 months before initiating treatment), unstable angina, congestive heart failure (new york heart association class ≥grade ii) , serious arrhythmia which needs medication during the study and may affect the study or can not be controlled by drugs
boolean
C0007222 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C0027051 (UMLS CUI [3])
C0002965 (UMLS CUI [4])
C0018802 (UMLS CUI [5,1])
C1275491 (UMLS CUI [5,2])
C0003811 (UMLS CUI [6,1])
C0205404 (UMLS CUI [6,2])
C1514873 (UMLS CUI [6,3])
C0013227 (UMLS CUI [6,4])
C0003811 (UMLS CUI [7,1])
C0392760 (UMLS CUI [7,2])
C0008976 (UMLS CUI [7,3])
C0003811 (UMLS CUI [8,1])
C0013216 (UMLS CUI [8,2])
C1272705 (UMLS CUI [8,3])
Wound, non-healed | Peptic Ulcer | Fracture
Item
unhealed wounds, active peptic ulcer or fracture
boolean
C0750433 (UMLS CUI [1])
C0030920 (UMLS CUI [2])
C0016658 (UMLS CUI [3])
Digestive System Fistula | Gastrointestinal perforation | Abdominal Abscess
Item
gastrointestinal fistula, gastrointestinal perforation or intra-abdominal abscess within 6 months before enrollment
boolean
C0079238 (UMLS CUI [1])
C0151664 (UMLS CUI [2])
C0243001 (UMLS CUI [3])
Gender Uterus Intact | Menopause Excluded | Contraceptive methods Unwilling | Intrauterine Devices | Vaginal Spermicides | Contraception, Barrier | Female Sterilization | Gender Contraceptive methods Unwilling
Item
women with intact uterus (menopause more than two years excluded) who are unwilling to take effective non-hormonal contraception (iud, spermicide barrier birth control device or sterilization) during the study. male who are unwilling to take effective contraceptive measures during the study
boolean
C0079399 (UMLS CUI [1,1])
C0042149 (UMLS CUI [1,2])
C0205266 (UMLS CUI [1,3])
C0025320 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
C0700589 (UMLS CUI [3,1])
C0558080 (UMLS CUI [3,2])
C0021900 (UMLS CUI [4])
C0087145 (UMLS CUI [5])
C0004764 (UMLS CUI [6])
C0015787 (UMLS CUI [7])
C0079399 (UMLS CUI [8,1])
C0700589 (UMLS CUI [8,2])
C0558080 (UMLS CUI [8,3])
Study Subject Participation Status
Item
participated in other clinical trials within 28 days before the initiation of treatment.
boolean
C2348568 (UMLS CUI [1])
Hypersensitivity Investigational New Drugs
Item
allergic to any of the study drugs
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial